×
About 1,430 results

ALLMedicine™ Sputum Culture Center

Research & Reviews  449 results

Pharmacokinetic-pharmacodynamic determinants of clinical outcomes for rifampin-resistan...
https://doi.org/10.1093/cid/ciac511
Clinical Infectious Diseases : an Official Publication Of... Heysell SK, Mpagama SG et. al.

Jun 23rd, 2022 - Treatment of rifampin-resistant and/or multidrug-resistant tuberculosis (RR/MDR-TB) requires multiple drugs and outcomes remain suboptimal. Some drugs are associated with improved outcome, however whether particular pharmacokinetic-pharmacodynamic...

Imaging findings of vertebral osteomyelitis caused by nontuberculous mycobacterial orga...
https://doi.org/10.1097/MD.0000000000029395 10.1136/bcr-2013-009597
Medicine Yu XJ, Lin YD et. al.

Jun 18th, 2022 - Prompt diagnosis of nontuberculous Mycobacterial (NTM) vertebral osteomyelitis is challenging, yet necessary to prevent serious morbidity and mortality. Here, we report 3 cases of vertebral osteomyelitis caused by NTM with imaging findings. Case 1...

Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
https://clinicaltrials.gov/ct2/show/NCT05327803

Jun 16th, 2022 - In the Phase 2 part of the study, approximately 80 patients will be randomized in a 1:1 ratio (40 patients receiving active epetraborole tablets and 40 patients receiving matching placebo tablets). The Phase 2 part of the study includes a blinded ...

Tuberculosis reinfection and relapse in eastern China: A prospective study using whole-...
https://doi.org/10.1016/j.cmi.2022.05.019
Clinical Microbiology and Infection : the Official Public... Liu Q, Qiu B et. al.

Jun 15th, 2022 - Tuberculosis recurrence after an initial successful treatment episode can occur from either reinfection or relapse. In a population-based sample and whole genome sequencing (WGS) in eastern China, we aimed to evaluate risk factors for tuberculosis...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  77 results

Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
https://clinicaltrials.gov/ct2/show/NCT05327803

Jun 16th, 2022 - In the Phase 2 part of the study, approximately 80 patients will be randomized in a 1:1 ratio (40 patients receiving active epetraborole tablets and 40 patients receiving matching placebo tablets). The Phase 2 part of the study includes a blinded ...

Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGS
https://clinicaltrials.gov/ct2/show/NCT04955821

Jun 14th, 2022 - Children receiving invasive mechanical ventilation in the intensive care unit (PICU) of the Pediatric Hospital of Fudan University will be included. Deep sputum samples were collected within 24 h and on day 5 of mechanical ventilation, respectivel...

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
https://clinicaltrials.gov/ct2/show/NCT04930744

Jun 13th, 2022 - The METHOD trial is a Phase II A randomized, open-label trial of metformin added to standard anti-tuberculosis treatment (ATT) and anti-retroviral therapy (ART) in TB/HIV co-infected patients. HIV-positive adults (treated or ART-naïve) newly diagn...

Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients
https://clinicaltrials.gov/ct2/show/NCT05134792

Jun 10th, 2022 - After randomization, Treatment and control groups will receive Parkland formula (4 ml/kg per percent total burn surface area; (TBSA), counting moderate (partial thickness) and severe (full thickness) burn area only) using Ringer's lactate solution...

Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis
https://clinicaltrials.gov/ct2/show/NCT05359315

Jun 1st, 2022 - Open prospective observational cohort study. During the recruitment phase, a preliminary assessment of eligibility and non-inclusion criteria will be carried out. Subject to prior compliance with all inclusion criteria and none of the exclusion cr...

see more →

News  44 results

TB Prevention in People With HIV: How Short Can We Go?
https://www.medscape.com/viewarticle/957312

Aug 26th, 2021 - A 3-month, 12-dose regimen of rifapentine and isoniazid (INH) was less toxic, had better compliance, and showed similar efficacy as 6 months of INH alone in preventing tuberculosis (TB) in people with HIV, according to the results of a clinical tr...

HIV+ Individuals on ART in Africa More Often Adhere to Short-Course TB Prophylaxis
https://www.medscape.com/viewarticle/957086

Aug 24th, 2021 - NEW YORK (Reuters Health) - Tuberculosis preventive therapy (TBT) completion rates were higher for short-course isoniazid-rifapentine than for isoniazid alone among individuals with HIV on antiretroviral therapy (ART) in Africa, a randomized trial...

Telehealth finds acceptance among patients with CF, clinicians
https://www.mdedge.com/chestphysician/article/232156/pulmonology/telehealth-finds-acceptance-among-patients-cf-clinicians
Jim Kling, MDedge News

Nov 19th, 2020 - Telehealth is widely accepted among individuals with cystic fibrosis (CF) and the physicians who treat them, according to three new studies. The surveys examined attitudes during the COVID-19 pandemic, which complicates interpretation of the surve.

Fast Five Quiz: Eosinophilic Asthma
https://reference.medscape.com/viewarticle/922981_3

Jul 6th, 2020 - Figure 1. Sputum culture Although the sputum eosinophilia level is the gold standard for diagnosing EA, this approach is not common because sputum processing and cell counting are too technical for most clinical centers. Nonetheless, there is cons...

Improving Flu Vaccine Uptake: Is Texting the Answer?
https://www.medscape.com/viewarticle/922849

Dec 18th, 2019 - The day before Rosie Baxter turned 4 years old, she sat in the garden of her home in Sydney, Australia, having a tea party with her twin sister Ellie. Both little girls had been inside with the flu for several days, and mom Kerry-Anne thought it w...

see more →